TRYPTOPHAN- AND PHENYLETHYLAMINE-DERIVED BETAXANTHINS FOR USE IN THE TREATMENT AND/OR PREVENTION OF CANCER

Patent number:

WO21009029

No items found.

Compounds of formula (I) of the betaxanthin family, or pharmaceutical compositions comprising the same, for use in the treatment and/or prevention of cancer and/or tumours, are described. In addition, the use of nutraceutical compositions, for the prevention of cancer or as chemopreventive compositions, comprising said compounds of formula (I) is described.

Countries:

Spain

Regions:

Region of Murcia

Centers:

UNIVERSIDAD DE MURCIA

Other entities:

Sectors:

Health

Subsectors:

Pharmaceuticals, Organic fine chemistry

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

- Obtaining larger amounts of betaxanthins compared to other methods used. - Obtaining pure betaxanthins with antitumor properties tested in the C. Elegans animal model.

Comments

Other related patents

Health

BIOTECHNOLOGICAL PRODUCTION OF D-DIBOA AND ITS CHLORINATED DERIVATES FROM ITS NITROPHENOXIDE-ACETATE PRECURSORS

Countries

Spain

Health

Aerospace

Automotive & Rail

Textile

Insole with heel cup for motorcycling boot

Countries

No items found.

Health

Procedure for storing and releasing protein-decorated nanoparticles on paper substrates

Countries

Spain

Get back to patents directory